Vosoritide’s first global phase 2 study showed an average increased growth rate of 1.8 cm per year in children with hypochondroplasia, a genetic cause of short stature in children, according to researchers from Children’s National Hospital.
Physicians are starting to shift pharma sales rep models from push to pull, study finds
Physicians are increasingly flipping the traditional sales rep model and instead of waiting for in-office visits, are reaching out for information. Almost one-third (30%) of